PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions

PURPOSE: The advent of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of advanced NSCLC, leading to a string of approvals in recent years. Herein, a narrative review on the role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in the ever-...

Descripción completa

Detalles Bibliográficos
Autores principales: Eze, Chukwuka, Schmidt-Hegemann, Nina-Sophie, Sawicki, Lino Morris, Kirchner, Julian, Roengvoraphoj, Olarn, Käsmann, Lukas, Mittlmeier, Lena M., Kunz, Wolfgang G., Tufman, Amanda, Dinkel, Julien, Ricke, Jens, Belka, Claus, Manapov, Farkhad, Unterrainer, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484219/
https://www.ncbi.nlm.nih.gov/pubmed/33760957
http://dx.doi.org/10.1007/s00259-021-05211-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484219/
https://www.ncbi.nlm.nih.gov/pubmed/33760957
http://dx.doi.org/10.1007/s00259-021-05211-8

Ejemplares similares